arrow
M

MacLean Hall

h lee moffitt cancer center & research institute
H指数:11
被引数:1,179

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients
2025-12-180
PRE
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma

病例报告:肿瘤浸润淋巴细胞疗法在一名患有转移性黑色素瘤和慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中的持久应答

2025-11-170
OAAI
IMMU-28. Cerebrospinal Fluid-Derived Tumor Reactive T cells (CSF-TRT cells) As Potential Adoptive Cell Therapy (ACT) for Leptomeningeal Disease (LMD) from Melanoma and Other Solid Tumors

IMMU-28. 脑脊液来源的肿瘤反应性T细胞(CSF-TRT细胞)作为黑色素瘤及其他实体瘤所致软脑膜疾病的潜在过继细胞疗法(ACT)

2025-11-110
OA
Defining the tumor-infiltrating lymphocyte antigenic landscape in head and neck cancer
2025-11-010
PRE
A PAN-CANCER ATLAS OF LEPTOMENINGEAL DISEASE REVEALS BRANCHED CHAIN KETO ACIDS DRIVE IMMUNOSUPPRESSION AND NEURODEGENERATION

髓膜疾病的全癌图谱揭示支链酮酸驱动免疫抑制和神经退行性变

2025-10-010
OAAI
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

新抗原特异性CD4肿瘤浸润淋巴细胞是转移性黑色素瘤患者过继细胞治疗产品中确定的有效效应物

2023-10-0610
OAAI
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer

膀胱癌肿瘤浸润淋巴细胞 (TIL) 的扩增

2018-07-2342
OAAI
Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Ipilimumab和过继细胞疗法与肿瘤浸润淋巴细胞联合治疗转移性黑色素瘤

2018-03-0277
OAAI